Terms: = Sarcomas AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Prognosis
193 results:
1. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract] [Full Text] [Related]
2. A novel nomogram and recursive partitioning analysis for predicting cancer-specific survival of patients with subcutaneous leiomyosarcoma.
Ji Q; Hu H; Li S; Tang J
Sci Rep; 2024 Feb; 14(1):2861. PubMed ID: 38311615
[TBL] [Abstract] [Full Text] [Related]
3. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING UTERINE LEIOMYOSARCOMA.
Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
[TBL] [Abstract] [Full Text] [Related]
4. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
[TBL] [Abstract] [Full Text] [Related]
5. Sex-dependent prognosis of Patients with Advanced Soft Tissue Sarcoma.
Pan M; Zhou MY; Jiang C; Zhang Z; Bui NQ; Bien J; Siy A; Achacoso N; Solorzano AV; Tse P; Chung E; Thomas S; Habel LA; Ganjoo KN
Clin Cancer Res; 2024 Jan; 30(2):413-419. PubMed ID: 37831066
[TBL] [Abstract] [Full Text] [Related]
6. Subcutaneous Leiomyosarcoma: An Aggressive Malignancy Portending a Significant Risk of Metastasis and Death.
Bresler SC; Gosnell HL; Ko JS; Angeles CV; Ronen S; Billings SD; Patel RM
Am J Surg Pathol; 2023 Dec; 47(12):1417-1424. PubMed ID: 37727934
[TBL] [Abstract] [Full Text] [Related]
7. Cutaneous leiomyosarcoma: a retrospective review of 45 cases.
Khan S; Asher R; Perkins W; Matin RN
Clin Exp Dermatol; 2023 Dec; 49(1):2-8. PubMed ID: 37595134
[TBL] [Abstract] [Full Text] [Related]
8. The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
Zagami P; Comandone A; Fiore M; Baldi GG; Grignani G; Vincenzi B; Gronchi A; Antonarelli G; Boglione A; Pennacchioli E; Curigliano G; Conforti F; De Pas TM
Cancer Med; 2023 Aug; 12(16):17047-17055. PubMed ID: 37455549
[TBL] [Abstract] [Full Text] [Related]
9. The Impact of O6-Methylguanine-DNA Methyltransferase (
Cannella L; Della Monica R; Marretta AL; Iervolino D; Vincenzi B; De Chiara AR; Clemente O; Buonaiuto M; Barretta ML; Di Mauro A; Di Marzo M; Guida M; Badalamenti G; Chiariotti L; Tafuto S
Cells; 2023 Jun; 12(12):. PubMed ID: 37371106
[TBL] [Abstract] [Full Text] [Related]
10. Hyalinising clear cell carcinoma of the lung: A case report and review of literature.
Chen L; Zhou N; Hu S; Wang F; Xu T; Li T; Fu Y; Luo Y; Chen Y
Medicine (Baltimore); 2023 Jun; 102(25):e34101. PubMed ID: 37352028
[TBL] [Abstract] [Full Text] [Related]
11. High grade leiomyosarcoma of the transverse colon with positive lymph node metastasis: to treat or not to treat with adjuvant radiation therapy?
Jenkins P; Joiner M; Kumar A; Miller SR
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37336627
[TBL] [Abstract] [Full Text] [Related]
12. Epithelioid leiomyosarcoma: An unusual presentation.
Kalantri SH; Joseph LD; Priyathersini N; Elangovan B
J Cancer Res Ther; 2023; 19(2):490-492. PubMed ID: 37313923
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
[TBL] [Abstract] [Full Text] [Related]
14. Organoid models derived from patients with malignant phyllodes tumor of the breast.
Chu X; Wu M; Yang J; Fu Y; Wang X; Wang H; Xiao Y; Chen D; He J
Breast Cancer Res Treat; 2023 Jul; 200(2):193-201. PubMed ID: 37204665
[TBL] [Abstract] [Full Text] [Related]
15. The biology and treatment of leiomyosarcomas.
Kerrison WGJ; Thway K; Jones RL; Huang PH
Crit Rev Oncol Hematol; 2023 Apr; 184():103955. PubMed ID: 36893945
[TBL] [Abstract] [Full Text] [Related]
16. Not All Leiomyosarcomas Are the Same: How to Best Classify lms.
Hickman A; Siontis BL
Curr Treat Options Oncol; 2023 Apr; 24(4):327-337. PubMed ID: 36884163
[TBL] [Abstract] [Full Text] [Related]
17. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
[TBL] [Abstract] [Full Text] [Related]
18. The analysis of the pyroptosis-related genes and hub gene tp63 ceRNA axis in osteosarcoma.
Han J; Hu Y; Ding S; Liu S; Wang H
Front Immunol; 2022; 13():974916. PubMed ID: 36389801
[TBL] [Abstract] [Full Text] [Related]
19. Successful Right Hepatectomy for Recurrent Liver Tumor Originating from an Inferior Vena Cava Leiomyosarcoma: A Follow-Up Case Report.
Nanashima A; Takamori H; Imamura N; Furukawa K; Hiyoshi M; Hamada T; Yano K; Tsuchimochi Y; Kamoto T
Am J Case Rep; 2022 Oct; 23():e938009. PubMed ID: 36301744
[TBL] [Abstract] [Full Text] [Related]
20. Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience.
Steinbrecher O; Brodowicz T; Raderer M; Scharrer A; Fabsits J; Lamm W
Oncology; 2023; 101(2):89-95. PubMed ID: 36273457
[TBL] [Abstract] [Full Text] [Related]
[Next]
